995 related articles for article (PubMed ID: 30189282)
1. Macular Morphology and Visual Acuity in Year Five of the Comparison of Age-related Macular Degeneration Treatments Trials.
Jaffe GJ; Ying GS; Toth CA; Daniel E; Grunwald JE; Martin DF; Maguire MG;
Ophthalmology; 2019 Feb; 126(2):252-260. PubMed ID: 30189282
[TBL] [Abstract][Full Text] [Related]
2. Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials.
Sharma S; Toth CA; Daniel E; Grunwald JE; Maguire MG; Ying GS; Huang J; Martin DF; Jaffe GJ;
Ophthalmology; 2016 Apr; 123(4):865-75. PubMed ID: 26783095
[TBL] [Abstract][Full Text] [Related]
3. Outcomes in Eyes with Retinal Angiomatous Proliferation in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT).
Daniel E; Shaffer J; Ying GS; Grunwald JE; Martin DF; Jaffe GJ; Maguire MG;
Ophthalmology; 2016 Mar; 123(3):609-16. PubMed ID: 26681392
[TBL] [Abstract][Full Text] [Related]
4. Risk of scar in the comparison of age-related macular degeneration treatments trials.
Daniel E; Toth CA; Grunwald JE; Jaffe GJ; Martin DF; Fine SL; Huang J; Ying GS; Hagstrom SA; Winter K; Maguire MG;
Ophthalmology; 2014 Mar; 121(3):656-66. PubMed ID: 24314839
[TBL] [Abstract][Full Text] [Related]
5. Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials.
Jaffe GJ; Martin DF; Toth CA; Daniel E; Maguire MG; Ying GS; Grunwald JE; Huang J;
Ophthalmology; 2013 Sep; 120(9):1860-70. PubMed ID: 23642377
[TBL] [Abstract][Full Text] [Related]
6. Angiographic Cystoid Macular Edema and Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials.
Shah N; Maguire MG; Martin DF; Shaffer J; Ying GS; Grunwald JE; Toth CA; Jaffe GJ; Daniel E;
Ophthalmology; 2016 Apr; 123(4):858-64. PubMed ID: 26778329
[TBL] [Abstract][Full Text] [Related]
7. Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials.
; Maguire MG; Martin DF; Ying GS; Jaffe GJ; Daniel E; Grunwald JE; Toth CA; Ferris FL; Fine SL
Ophthalmology; 2016 Aug; 123(8):1751-1761. PubMed ID: 27156698
[TBL] [Abstract][Full Text] [Related]
8. Predominantly Persistent Subretinal Fluid in the Comparison of Age-Related Macular Degeneration Treatments Trials.
Core JQ; Pistilli M; Daniel E; Grunwald JE; Toth CA; Jaffe GJ; Hua P; Martin DF; Ying GS; Maguire MG;
Ophthalmol Retina; 2021 Oct; 5(10):962-974. PubMed ID: 34126249
[TBL] [Abstract][Full Text] [Related]
9. Subretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments Trials.
Willoughby AS; Ying GS; Toth CA; Maguire MG; Burns RE; Grunwald JE; Daniel E; Jaffe GJ;
Ophthalmology; 2015 Sep; 122(9):1846-53.e5. PubMed ID: 26143666
[TBL] [Abstract][Full Text] [Related]
10. Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration.
Ying GS; Huang J; Maguire MG; Jaffe GJ; Grunwald JE; Toth C; Daniel E; Klein M; Pieramici D; Wells J; Martin DF;
Ophthalmology; 2013 Jan; 120(1):122-9. PubMed ID: 23047002
[TBL] [Abstract][Full Text] [Related]
11. Five-Year Follow-up of Nonfibrotic Scars in the Comparison of Age-Related Macular Degeneration Treatments Trials.
Daniel E; Ying GS; Kim BJ; Toth CA; Ferris F; Martin DF; Grunwald JE; Jaffe GJ; Dunaief JL; Pan W; Maguire MG;
Ophthalmology; 2019 May; 126(5):743-751. PubMed ID: 30476517
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of eyes with lesions composed of >50% blood in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT).
Altaweel MM; Daniel E; Martin DF; Mittra RA; Grunwald JE; Lai MM; Melamud A; Morse LS; Huang J; Ferris FL; Fine SL; Maguire MG; ;
Ophthalmology; 2015 Feb; 122(2):391-398.e5. PubMed ID: 25307130
[TBL] [Abstract][Full Text] [Related]
13. Tolerating Subretinal Fluid in Neovascular Age-Related Macular Degeneration Treated with Ranibizumab Using a Treat-and-Extend Regimen: FLUID Study 24-Month Results.
Guymer RH; Markey CM; McAllister IL; Gillies MC; Hunyor AP; Arnold JJ;
Ophthalmology; 2019 May; 126(5):723-734. PubMed ID: 30502372
[TBL] [Abstract][Full Text] [Related]
14. Incidence and Progression of Nongeographic Atrophy in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Clinical Trial.
Daniel E; Maguire MG; Grunwald JE; Toth CA; Jaffe GJ; Martin DF; Ying GS;
JAMA Ophthalmol; 2020 May; 138(5):510-518. PubMed ID: 32191267
[TBL] [Abstract][Full Text] [Related]
15. Development and Course of Scars in the Comparison of Age-Related Macular Degeneration Treatments Trials.
Daniel E; Pan W; Ying GS; Kim BJ; Grunwald JE; Ferris FL; Jaffe GJ; Toth CA; Martin DF; Fine SL; Maguire MG;
Ophthalmology; 2018 Jul; 125(7):1037-1046. PubMed ID: 29454660
[TBL] [Abstract][Full Text] [Related]
16. Influence of the Vitreomacular Interface on Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials.
Ciulla TA; Ying GS; Maguire MG; Martin DF; Jaffe GJ; Grunwald JE; Daniel E; Toth CA;
Ophthalmology; 2015 Jun; 122(6):1203-11. PubMed ID: 25824327
[TBL] [Abstract][Full Text] [Related]
17. CORRELATION OF SUBRETINAL HYPERREFLECTIVE MATERIAL MORPHOLOGY AND VISUAL ACUITY IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Kumar JB; Stinnett S; Han JIL; Jaffe GJ
Retina; 2020 May; 40(5):845-856. PubMed ID: 31305505
[TBL] [Abstract][Full Text] [Related]
18. Macular Atrophy in the HARBOR Study for Neovascular Age-Related Macular Degeneration.
Sadda SR; Tuomi LL; Ding B; Fung AE; Hopkins JJ
Ophthalmology; 2018 Jun; 125(6):878-886. PubMed ID: 29477692
[TBL] [Abstract][Full Text] [Related]
19. Outcomes by Baseline Choroidal Neovascularization Features in Age-Related Macular Degeneration: A Post Hoc Analysis of the VIEW Studies.
Steinle NC; Du W; Gibson A; Saroj N
Ophthalmol Retina; 2021 Feb; 5(2):141-150. PubMed ID: 32652314
[TBL] [Abstract][Full Text] [Related]
20. Distribution of OCT Features within Areas of Macular Atrophy or Scar after 2 Years of Anti-VEGF Treatment for Neovascular AMD in CATT.
Toth CA; Tai V; Pistilli M; Chiu SJ; Winter KP; Daniel E; Grunwald JE; Jaffe GJ; Martin DF; Ying GS; Farsiu S; Maguire MG;
Ophthalmol Retina; 2019 Apr; 3(4):316-325. PubMed ID: 31014683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
